Cases & Deals

  • Home
  • Practices
  • Endo Pharmaceuticals successfully completes tender offer for shares of HealthTronics for $223 million

Share

Endo Pharmaceuticals successfully completes tender offer for shares of HealthTronics for $223 million

July 2010

Client(s) Endo Pharmaceuticals Inc.

Jones Day advised Endo Pharmaceuticals Inc. as Georgia counsel in the $223 million tender offer for all of the outstanding shares of common stock of HealthTronics, Inc.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.